Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.

Researchers at UT Southwestern Medical Center discovered that genetically modifying fat cells in obese mice to produce higher levels of the glucose-dependent insulinotropic polypeptide receptor ...

O bese mice whose fat cells were genetically altered to produce an increased amount of the glucose-dependent insulinotropic polypeptide receptor (GIPR) lost more than a third of their body weight ...

and glucose-dependent insulinotropic polypeptide (GIP). Currently, there are two approved GLP-1 and one combined GIP/ GLP-1 receptor agonists indicated for chronic weight management. The advent of ...

New research suggests that Ozempic and similar weight loss medications have the potential to be as big a game changer in ...

Learn how the complex signaling features of these receptors are illuminating diabetes research. Diabetes results from elevated blood glucose levels that stems from the decreased secretion and/or ...

Unlike others in its class, tirzepatide targets two hormones — glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). This double action makes it particularly ...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its ...

Tirzepatide, on the other hand, has been hypothesized to combine GLP-1 and GIP receptor activation. GIP, or glucose-dependent insulinotropic polypeptide, is another incretin hormone that ...